Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,650.00
Ask: 1,710.00
Change: 0.00 (0.00%)
Spread: 60.00 (3.636%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks rise but markets cautious ahead of Fed decision

Wed, 30th Apr 2014 11:53

- Markets cautious ahead of FOMC outcome- Eurozone inflation picks up but misses consensus- Heritage Oil jumps on takeover offer- Shell and Tullow lead markets highertechMARK 2,775.59 -0.56%FTSE 100 6,776.83 +0.10%FTSE 250 15,813.39 -0.52%UK stocks were trading slightly higher on Wednesday but were rangebound in morning trade after markets hit an eight-week high the previous session.A raft of economic data and corporate earnings were keep traders busy today, while nervousness ahead of this evening's policy decision by the Federal Reserve prompted many to scale back risk.The Federal Open Market Committee begun its two-day policy meeting yesterday and is widely expected to continue tapering its asset purchase programme by $10bn each meeting. This will bring the monthly stock of bond buying down from $55bn to $45bn."It's very unlikely that they'd change this amount or announce anything different when there's no accompanying press conference. It would cause unnecessary panic in the markets, which the Fed has tried to avoid when possible," said Market Analyst Craig Erlam from Alpari.The FTSE 100 was trading 0.1% higher at 6,777 by midday after closing at 6,769.91 on Tuesday afternoon, its highest finish since March 6th.In economic news this morning, Eurozone inflation rose less than expected in April, according to the flash estimate published this morning by Eurostat. The annual rate of consumer price inflation rose to 0.7% this month after prices rose by 0.5% in March. However, this compared to the consensus estimate for a 0.8% rise. US stock futures were pointing to a lower start on Wall Street later on ahead of upcoming mortgage applications data and the ADP employment report, as well as a reading of US economic growth for the first quarter. Heritage Oil jumps after takeover offerHeritage Oil shares surged this morning after Energy Investments Global offer 320p a share to take over the company, some 25% above yesterday's closing price. The offer values the company at £924m. Heritage also announced today that profits more than doubled in 2013.Oil major Royal Dutch Shell rose strongly despite saying that first-quarter underlying earnings fell by 3%, which exclude £2.9bn of impairments in its Downstream division.Sector peer Tullow also gained after saying it is on track to meet its 2014 production guidance following a good performance since the start of the year.Rolls-Royce, the power systems group, was also higher after confirming media speculation that it is in talks with German engineer Siemens about the possible sale of its energy gas turbine and compressor division.High street retail giant Next was swinging between gains and losses despite lifting its guidance for sales and profits this year after a strong performance in the first quarter. The company also announced that it would pay a special dividend and raise the limit of its share buyback.Heading the other way was insurer Standard Life after underwhelming with a 1.5% rise in assets under administration in the first quarter.GlaxoSmithKline was in the red despite meeting expectations with a 2% rise in constant-currency core earnings per share to 21p. Revenues however declined by 2% to £5.6bn.Admiral fell after going ex-dividend, along with others including ITV, Croda, Cobham, G4S, Ferrexpo, Tesco, Reed Elsevier, Travis Perkins and Weir.FTSE 100 - RisersRoyal Dutch Shell 'B' (RDSB) 2,547.00p +4.77%Royal Dutch Shell 'A' (RDSA) 2,372.50p +4.06%Barratt Developments (BDEV) 364.50p +3.76%WPP (WPP) 1,264.00p +2.27%Capita (CPI) 1,076.00p +1.99%Tullow Oil (TLW) 881.00p +1.79%Rolls-Royce Holdings (RR.) 1,039.00p +1.76%BG Group (BG.) 1,199.50p +1.61%Severn Trent (SVT) 1,853.00p +1.59%Shire Plc (SHP) 3,299.00p +1.10%FTSE 100 - FallersAdmiral Group (ADM) 1,390.00p -3.61%Tesco (TSCO) 293.05p -3.38%Hargreaves Lansdown (HL.) 1,161.00p -2.19%Reed Elsevier (REL) 864.50p -2.10%British American Tobacco (BATS) 3,415.00p -2.06%William Hill (WMH) 340.10p -2.04%GlaxoSmithKline (GSK) 1,632.00p -2.01%ITV (ITV) 180.00p -2.01%Imperial Tobacco Group (IMT) 2,556.00p -1.88%Weir Group (WEIR) 2,679.00p -1.83%FTSE 250 - RisersHeritage Oil (HOIL) 313.40p +22.61%Aveva Group (AVV) 2,097.00p +7.26%Ophir Energy (OPHR) 265.00p +5.49%Afren (AFR) 159.00p +3.72%Playtech (PTEC) 654.50p +2.51%Cairn Energy (CNE) 183.70p +1.94%Bellway (BWY) 1,424.00p +1.79%Premier Oil (PMO) 343.00p +1.72%Taylor Wimpey (TW.) 104.10p +1.46%Soco International (SIA) 424.30p +1.39%FTSE 250 - FallersCSR (CSR) 604.00p -5.85%Supergroup (SGP) 1,317.00p -4.08%UBM (UBM) 646.00p -3.94%Hunting (HTG) 850.00p -3.57%SIG (SHI) 192.00p -3.57%Kazakhmys (KAZ) 228.60p -3.54%Elementis (ELM) 275.70p -3.47%Petra Diamonds Ltd.(DI) (PDL) 162.20p -3.45%IP Group (IPO) 174.10p -3.28%Cranswick (CWK) 1,197.00p -3.23%BC
More News
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.